Crossmark Global Holdings, Inc. Charles River Laboratories International, Inc. Transaction History
Crossmark Global Holdings, Inc.
- $5.61 Billion
- Q3 2024
A detailed history of Crossmark Global Holdings, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 4,995 shares of CRL stock, worth $987,761. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,995
Previous 5,968
16.3%
Holding current value
$987,761
Previous $1.23 Million
20.19%
% of portfolio
0.02%
Previous 0.02%
Shares
29 transactions
Others Institutions Holding CRL
# of Institutions
698Shares Held
52.3MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$1.01 Billion0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$740 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$421 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$384 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.1B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...